WebTraductions en contexte de "intravenous and subcutaneous administration" en anglais-français avec Reverso Context : The clinical relevance of the different peak plasma concentrations after intravenous and subcutaneous administration of cladribine has not been examined. WebJun 1, 2007 · Samples for pharmacokinetic analysis were collected up to 28 days after administration of the first QM darbepoetin alfa dose. Absorption after SC injection was slow in all patients, with peak concentrations of 0.75–6.29 ng/ml reached at 34–58 h post-dose, respectively, followed by a generally monophasic decline.
Administration of CKD-11101 to healthy subjects DDDT
Web*Data from a multicenter, randomized, open-label study comparing epoetin, given 1, 2, or 3 times weekly IV or SC, with ARANESP ®, at a reduced dose frequency, in dialysis patients (N = 522).Dose adjustments were made as necessary and per study protocol to maintain individual patients’ Hb within a target range of –1.0 to +1.5 g/dL of their baseline Hb and … WebBackground: Studies have consistently shown the superior dosing efficiency of subcutaneous (s.c.) compared to intravenous (i.v.) erythropoietin (r-HuEPO). Unlike r-HuEPO, data from pivotal darbepoetin trials support s.c. and i.v. dosing equivalence, however, no blinded cross-over randomized studies of s.c. and i.v. dose efficiency or … photographer\u0027s ephemeris 3d
Pharmacokinetic study of darbepoetin alfa: absorption, …
WebThis medication is given as an injection under the skin or into a vein as directed by your doctor. Hemodialysis patients should receive this medication by injection into a vein. If … WebMethods: This study was performed in two parts for healthy subjects. In each period, CKD-11101 and reference, both at 60 μg, were administered via intravenous (IV) or subcutaneous (SC) route of administration. Results: After both IV or SC dose, the geometric mean ratio (GMR) of CKD-11101 to reference drug and its 90% confidence … WebDarbepoetin alfa is a recombinant form of human erythropoietin used to increase differentiation of progenitor cells to red blood cells in the treatment of anemia. ... Subcutaneous: Injection, solution: Subcutaneous: 10 μg: Injection, solution: Subcutaneous: 100 μg: Injection, solution: Subcutaneous: 130 μg: Injection, solution: … photographer\\u0027s playbook